Whales with a lot of money to spend have taken a noticeably bullish stance on Moderna.
Looking at options history for Moderna MRNA we detected 38 trades.
If we consider the specifics of each trade, it is accurate to state that 57% of the investors opened trades with bullish expectations and 36% with bearish.
From the overall spotted trades, 30 are puts, for a total amount of $1,594,617 and 8, calls, for a total amount of $394,717.
What's The Price Target?
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $22.5 to $60.0 for Moderna over the last 3 months.
Volume & Open Interest Development
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Moderna's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Moderna's substantial trades, within a strike price spectrum from $22.5 to $60.0 over the preceding 30 days.
Moderna Option Volume And Open Interest Over Last 30 Days
Significant Options Trades Detected:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MRNA | PUT | SWEEP | BEARISH | 03/20/26 | $33.15 | $33.15 | $33.15 | $60.00 | $198.9K | 215 | 49 |
| MRNA | CALL | TRADE | BULLISH | 01/16/26 | $6.3 | $6.15 | $6.3 | $30.00 | $126.0K | 1.0K | 215 |
| MRNA | PUT | TRADE | BEARISH | 06/18/26 | $8.45 | $7.45 | $8.45 | $30.00 | $114.0K | 195 | 228 |
| MRNA | PUT | TRADE | BULLISH | 01/16/26 | $15.45 | $14.65 | $14.65 | $40.00 | $84.9K | 6.4K | 119 |
| MRNA | PUT | SWEEP | BEARISH | 04/17/25 | $4.3 | $4.25 | $4.25 | $31.00 | $83.3K | 258 | 199 |
About Moderna
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
In light of the recent options history for Moderna, it's now appropriate to focus on the company itself. We aim to explore its current performance.
Where Is Moderna Standing Right Now?
- Currently trading with a volume of 15,324,366, the MRNA's price is down by -8.44%, now at $28.5.
- RSI readings suggest the stock is currently is currently neutral between overbought and oversold.
- Anticipated earnings release is in 31 days.
Expert Opinions on Moderna
Over the past month, 2 industry analysts have shared their insights on this stock, proposing an average target price of $36.5.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access. * Maintaining their stance, an analyst from JP Morgan continues to hold a Underweight rating for Moderna, targeting a price of $33. * Reflecting concerns, an analyst from Citigroup lowers its rating to Neutral with a new price target of $40.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Moderna with Benzinga Pro for real-time alerts.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
